Paris, France – Advesya, a company dedicated to developing novel therapies targeting IL-1RAP, announced that it will present two posters at the 66th American Society of Hematology (ASH) Annual Meeting, to be held in San Diego, California, from December 7 to 10, 2024. First Poster Presentation: Our collaborators at ALFA [...]
ADV-101: A Topoisomerase I Inhibitor ADC Targeting IL-1RAP Demonstrates Promising Efficacy in Preclinical Esophageal Cancer Models With an estimated 604,000 new cases diagnosed worldwide in 2020, Oesophageal cancer ranks as the seventh most common cancer globally and remains a challenging malignancy with poor prognosis. Chronic inflammation, driven by IL-1-related cytokines, [...]
Paris, France – Advesya, a company dedicated to developing novel therapies targeting IL-1RAP, announced that it will present two posters at the 66th American Society of Hematology (ASH) Annual Meeting, [...]
ADV-101: A Topoisomerase I Inhibitor ADC Targeting IL-1RAP Demonstrates Promising Efficacy in Preclinical Esophageal Cancer Models With an estimated 604,000 new cases diagnosed worldwide in 2020, Oesophageal cancer ranks as [...]
Advesya Granted EMA Clinical Trial Application (CTA) for CCTx-001, Its Lead Investigational Cell Therapy Asset Targeting IL-1RAP for the Treatment of Relapsed/Refractory Acute Myeloid Leukaemia Paris [...]
CCTx-001, A FIRST IN CLASS AUTOLOGOUS ANTI-IL-1RAP CAR T-CELL THERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY AML Topic: Acute myeloid leukemia – Biology & translational research Background: Relapsed/refractory acute myeloid leukaemia [...]
Abstract 6322: CCTx-001 CAR T-cells targeting the AML specific antigen IL-1RAP show robust pre-clinical anti-tumor efficacy Abstract Despite significant advancements in acute myeloid leukemia (AML) treatment, patients with relapsed/refractory (r/r) [...]
Abstract 2360: ADV101, a first-in-class IL-1RAP ADC demonstrates significant anti-tumor activity in solid tumor models Abstract Chronic inflammation is intricately linked to cancer development, and the IL-1 cytokine family stands [...]
© 2024 advesya | All rights reserved
